产品封面图

Cellular Technology Ltd (CTL)公

司介绍
收藏
  • 询价
  • 玉博
  • 玉博
  • 2025年07月13日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料

    【简单介绍】

    国凯斯西储大学(CWRU)的病理学教授Paul V. Lehmann博士开发出新一代ELISPOT检测技术,继而创立CTL公司,致力于为全球用户提供最精确的ELISPOT检测仪器和解决方案。

    【详细说明】

    美国Cellular Technology Ltd (CTL) www.elispot.cn www.immunospot.com
     Cellular Technology Ltd (CTL)是世界领先和全球最大的 ELISPOT 技术解决方案提供商。CTL 由 1996 年在美国 Ohio Case Western Reverse University 大学发明新一代 ELISPOT 分析方法的 Paul V. Lehmann 教授所创建。
    CTL 是 ELISPOT 技术的世界领导者,首次创立了当代新型 ELISPOT 方法,将 ELISPOT 技术提升到了精确科学的高度;首次将图像分析引入到 ELISPOT中,制造出世界上第一台商业 ELISPOT 分析仪。CTL 15年来一直从事细胞免疫学研究,专注于 ELISPOT 领域已经超过 10 年的历史。CTL 是美国 NIH 免疫耐受网唯一指定的 ELISPOT 分析实验室和分析仪提供商。CTL 提供 ELISPOT 分析仪硬件、软件和相关服务。是世界上唯一能提供 ELISPOT 服务,包括双色分析、质量控制和大规模 ELISPOT 协约服务在内的技术提供商。敬请联系我们,探讨 ELISPOT 技术如何为您的科研、临床和新药研制等领域提供有力的帮助。
    Cellular Technology Ltd. was formed in 1998 by Dr. Paul V. Lehmann, a Professor at the Case Western Reserve University School of Medicine.

    Dr. Lehmann is a leader in the field of T cell immunology with over 20 high ranking publications dedicated to establishing the scientific basis of cytokine ELISPOT analysis.

    Dr. Lehmann developed the original ImmunoSpot technology in order to conduct his own research more effectively. The ImmunoSpot platform is the most frequently referenced in the scientific literature in this field and is widely accepted to be the gold standard. Applications of ImmunoSpot technology include diagnosis and drug discovery for infectious diseases such as HIV and tuberculosis, better understanding and treatment of allergies and autoimmunity, the ability to predict rejection/acceptance responses in organ transplantation and significant improvements in vaccine development and monitoring including for various cancers where post treatment monitoring will be a key part of the therapy.

    Dr. Lehmann pioneered the development of tools to accurately and reproducibly measure T cell responses. Dr. Lehmann and CTL designed and constructed the world’s very first ELISPOT reader under US Patent No: 6,410,252 (Methods for Measuring T Cell Cytokines, issued June 25, 2002). The company has been at the forefront of this field ever since.

    In 2001, CTL established a laboratory to provide assay services to companies and academic researchers involved in cellular immunology research, drug discovery and drug development. These services include immunogenicity testing, plate scanning and analysis, and ELISPOT assay training.

    Within recent years, CTL has expanded its platform to include additional products and services for those in the scientific community. These include cryopreserved PBMC, serum-free media, plaque and colony counters, and expanded contract research services.

    Headquartered in Cleveland, Ohio, CTL has expanded to include offices in China, Germany, and Japan.


    CTL has been recognized as the leader in basic science publications about (and clinical application of) ELISPOT assays, instrumentation, software, and reagent solutions. CTL is the only entity that specializes in developing ELISPOT instrumentation, assays, and their implementation in GLP compliant contract research. As such, CTL has been recognized by the Cancer Vaccine Consortium as the ELISPOT reference laboratory and has been awarded by the U.S. National Institutes of Health (NIH) a contract for the validation of the ELISPOT assay for clinical trials.

    In recent years, CTL has expanded to include instrumentation for evaluating bioassays as well as reagent solutions including cryopreserved PBMC samples and serum-free media.

    Because of its commitment to world-class quality and performance, CTL was awarded the 2005 “Excellence in Exporting” award by the State of Ohio’s Governor’s Office.

    Today, CTL’s instrumentation and products are placed in over 30 countries, with over 350 institutes adopting the ImmunoSpot® platform for their immunological research needs.


    产品细节图片1
    IKA| http://www.ybiotechmall.com/enstyle/firstcatalog_3294464_IKA_1.html;
    IWAKI| http://www.ybiotechmall.com/enstyle/firstcatalog_3294465_IWAKI_1.html;
    Invivoscribe| http://www.ybiotechmall.com/enstyle/firstcatalog_3294466_Invivoscribe_1.html;
    Inbio| http://www.ybiotechmall.com/enstyle/firstcatalog_3294467_Inbio_1.html;
    iNtRONbio| http://www.ybiotechmall.com/enstyle/firstcatalog_3294468_iNtRONbio_1.html;
    Ingeny| http://www.ybiotechmall.com/enstyle/firstcatalog_3294469_Ingeny_1.html;
    Novex| http://www.ybiotechmall.com/enstyle/firstcatalog_3294470_Novex_1.html;
    Molecular Probes| http://www.ybiotechmall.com/enstyle/firstcatalog_3294471_Molecular-Probes_1.html;
    TaqMan| http://www.ybiotechmall.com/enstyle/firstcatalog_3294472_TaqMan_1.html;
    life technologies| http://www.ybiotechmall.com/enstyle/firstcatalog_3294473_life-technologies_1.html;

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    相关实验
    • Use of Ribozymes in Cellular Aging Research

      , there has been considerable interest in the utility of ribozymes as gene therapeutic agents to silence disease-causing genes. This technology is not perfect, but extensive efforts to improve upon natural design of ribozymes have enabled these RNA molecules to perform various

    • The In Situ PCR:Amplification and Detection in a Cellular Co

      contains as little as a single copy of nucleic acid, that molecule amplified by the PCR, and detected after amplification. In situ hybridization applies and extrapolates the technology of nucleic acid hybridization to the single Cell level

    • Gene Array Technology and the Study of Platelets and Megakaryocytes

      The expression profile of the complete set of cellular genes or global gene expression provides a remarkable snapshot of physiological and pathophysiological mechanisms underlying cell regulation. Thus, accurate and precise measurements

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    询价
    上海玉博生物科技有限公司
    2025年07月15日询价
    ¥3904
    深圳欣博盛生物科技有限公司
    2025年07月15日询价
    询价
    艾美捷科技有限公司
    2025年07月15日询价
    ¥195
    上海三抒生物科技有限公司
    2025年10月31日询价
    ¥100
    上海玉研科学仪器有限公司
    2026年01月19日询价
    Cellular Technology Ltd (CTL)公司介绍
    询价